Gilead Stock Is Up 25% This Year, Time To Sell?
- Wednesday, May 13, 2020, 7:12
- Market
- Add a comment
Gilead Sciences, a biotech company best known for its anti-viral drugs, has seen its stock outperform through the coronavirus, rising by almost 25% year-to-date, compared to the broader S&P which is down ~10%. The optimism surrounding Gilead stems from its experimental anti-viral drug Remdesivir…
About the Author
admin123 has written 23527 stories on this site.
